-transparent.png){kind=logo}
Twenty-five children with IgA nephropathy were studied by serial renal biopsy to investigate C3 deposition. The children were classified into three groups according to the immunofluorescent (IF) course of C3 deposition: group I (N = 9): unchanged or slightly decreased; group II (N = 4): changed to segmental deposition; and group III (N = 12): changed to negative deposition. Histological changes were scored semiquantitatively as an activity index (cellular proliferation, necrosis, interstitial cell infiltration and cellular crescents) and a chronicity index (mesangial sclerosis, segmental and global glomerular sclerosis, adhesion, fibrous crescents and tubulo-interstitial change). The IF findings were scored semiquantitatively and laboratory data were also studied. The following results were obtained: 1. Normal urinalysis was often observed in group III; 2. The IF scores of IgA and IgG were decreased at the second biopsy in all groups, most notably in group III; 3. The activity indices at second biopsies were decreased in all groups, most notably in groups II and III, consistently with our previous study which showed that C3 deposition increases in accordance with histological activity; 4. The chronicity index was unchanged in all groups and C3 deposition did not reflect histological chronicity. Thus, this study indicates that C3 deposition occurs as the disease progresses and reflects histological activity.
M Hara, and
R Yoshida, and
S Inaba, and
A Higuchi, and
Y Suzuki, and
T Okada, and
T Tanizawa
April 1987,
Nihon Jinzo Gakkai shi,
M Hara, and
R Yoshida, and
S Inaba, and
A Higuchi, and
Y Suzuki, and
T Okada, and
T Tanizawa
July 2013,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Hara, and
R Yoshida, and
S Inaba, and
A Higuchi, and
Y Suzuki, and
T Okada, and
T Tanizawa
October 1982,
Laboratory investigation; a journal of technical methods and pathology,
M Hara, and
R Yoshida, and
S Inaba, and
A Higuchi, and
Y Suzuki, and
T Okada, and
T Tanizawa
March 2023,
Journal of nephrology,
M Hara, and
R Yoshida, and
S Inaba, and
A Higuchi, and
Y Suzuki, and
T Okada, and
T Tanizawa
June 2021,
Clinical and experimental nephrology,
M Hara, and
R Yoshida, and
S Inaba, and
A Higuchi, and
Y Suzuki, and
T Okada, and
T Tanizawa
January 2012,
PloS one,
M Hara, and
R Yoshida, and
S Inaba, and
A Higuchi, and
Y Suzuki, and
T Okada, and
T Tanizawa
February 2020,
Clinical immunology (Orlando, Fla.),
M Hara, and
R Yoshida, and
S Inaba, and
A Higuchi, and
Y Suzuki, and
T Okada, and
T Tanizawa
March 2021,
Translational pediatrics,
M Hara, and
R Yoshida, and
S Inaba, and
A Higuchi, and
Y Suzuki, and
T Okada, and
T Tanizawa
December 2023,
Clinical journal of the American Society of Nephrology : CJASN,
M Hara, and
R Yoshida, and
S Inaba, and
A Higuchi, and
Y Suzuki, and
T Okada, and
T Tanizawa
January 1991,
Nephron,
